HTG Molecular Diagnostics vs Predicine

HTG Molecular Diagnostics logo

HTG Molecular Diagnostics

HTG is focused on advancing precision medicine

33 employees · est. 1997 · Tucson, United States

VS
Predicine logo

Predicine

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees · est. 2015 · Hayward, United States

HTG Molecular Diagnostics is the older company (1997 vs 2015); Predicine is the larger of the two.

Side-by-Side Comparison

HTG Molecular Diagnostics Predicine
Founded
1997 older 2015
Headquarters
Tucson, United States Hayward, United States
Employees
33 89 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Life Sciences
Funding Stage
Post-IPO Equity Not tracked yet
Total Funding
$106.51M Not tracked yet
Funding Rounds
14 Not tracked yet
Taxonomy
Precision MedicineTranscriptome ProfilingClinical DiagnosticsTherapeuticsBiopharma PartnershipsRNA Platform Technologies +9 Precision MedicineLiquid BiopsyOncology DiagnosticsBiomarker DevelopmentGenomic ProfilingClinical Trials Support +9
Website
htgmolecular.com predicine.com
HTG Molecular Diagnostics logo

About HTG Molecular Diagnostics

HTG Molecular Diagnostics is a biotechnology startup headquartered in the United States. Since its founding in 1997, the company has been dedicated to advancing precision medicine. Their mission, encapsulated in the slogan "HTG is focused on advancing precision medicine," resonates with the growing...

Predicine logo

About Predicine

Predicine is a global molecular insights company that focuses on advancing precision medicine in oncology. The company has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology, enabling minimally invasive molecular diagnosis for treatment selection, therapy monito...

Also comparing in this category

Comparing more than these two?

Get HTG Molecular Diagnostics, Predicine and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does HTG Molecular Diagnostics compare?

A PDF of HTG Molecular Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

HTG Molecular Diagnostics was founded in 1997, based in Tucson, United States, with 33 employees. HTG Molecular Diagnostics is a biotechnology startup headquartered in the United States. Since its founding in 1997, the company has been dedicated to advancing precision medicine. Their mission, enca. Predicine was founded in 2015, based in Hayward, United States, with 89 employees. Predicine is a global molecular insights company that focuses on advancing precision medicine in oncology. The company has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy.
HTG Molecular Diagnostics has raised $106.51M and Predicine no disclosed funding. Latest stage: HTG Molecular Diagnostics Post-IPO Equity.
Both work in Biotechnology, Health Care and Life Sciences and list precision medicine and biopharma partnerships among their focus areas.

Compare HTG Molecular Diagnostics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at HTG Molecular Diagnostics on 11 Sep 2024, and Predicine on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes